Association Between Baseline Anti-Cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients With RA
mediaposted on 2021-05-05, 16:39 authored by Adis journals on behalf of, Leslie R. Harrold, Joshua Bryson, Thomas Lehman, Joe Zhuo, Sheng Gao, Xue Han, Amy Schrader, Sabrina Rebello, Dimitrios A. Pappas, Tanya Sommers, Joel M. Kremer
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.